Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 31 references it cites were found in a registry or an index.

Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial

Open access

Abstract

Introduction: The present study aimed to evaluate the effects of flash glucose monitoring (FGM) and conventional self-monitoring of blood glucose (SMBG) on glycemic control in patients with non-insulin-treated type 2 diabetes. Research design and methods: In this 24-week, multicenter, open-label, randomized (1:1), parallel-group study, patients with non-insulin-treated type 2 diabetes at five hospitals in Japan were randomly assigned to the FGM (n=49) or SMBG (n=51) groups and were provided each device for 12 weeks. The primary outcome was change in glycated hemoglobin (HbA1c) level, and was compared using analysis of covariance model that included baseline values and group as covariates. Results: Forty-eight participants in the FGM group and 45 in the SMBG group completed the study. The mean HbA1c levels were 7.83% (62.1 mmol/mol) in the FGM group and 7.84% (62.2 mmol/mol) in the SMBG group at baseline, and the values were reduced in both FGM (−0.43% (−4.7 mmol/mol), p<0.001) and SMBG groups (−0.30% (−3.3 mmol/mol), p=0.001) at 12 weeks. On the other hand, HbA1c was significantly decreased from baseline values in the FGM group, but not in the SMBG group at 24 weeks (FGM: −0.46% (−5.0 mmol/mol), p<0.001; SMBG: −0.17% (−1.8 mmol/mol), p=0.124); a significant between-group difference was also observed (difference −0.29% (−3.2 mmol/mol), p=0.022). Diabetes Treatment Satisfaction Questionnaire score was significantly improved, and the mean glucose levels, SD of glucose, mean amplitude of glycemic excursions and time in hyperglycemia were significantly decreased in the FGM group compared with the SMBG group. Conclusions: Glycemic control was better with FGM than with SMBG after cessation of glucose monitoring in patients with non-insulin-treated type 2 diabetes. Trial registration number: UMIN000026452, jRCTs041180082.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2019-001115

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic illustration of the study design. One-hundred participants were randomly assigned to the flash glucose monitoring (FGM) (n=49) or self-monitoring of blood glucose (SMBG) (n=51) group. Forty-eight participants in the FGM group and 45 participants in the SMBG group completed the study.
Figure 1 Schematic illustration of the study design. One-hundred participants were randomly assigned to the flash glucose monitoring (FGM) (n=49) or self-monitoring of blood glucose (SMBG) (n=51) group. Forty-eight participants in the FGM group and 45 participants in the SMBG group completed the study.CC BY-NC · PubMed Central
Figure 2 Change in glycated hemoglobin (HbA1c). HbA1c was reduced from baseline level in both groups at 12 weeks (flash glucose monitoring (FGM): −0.43% (−4.7 mmol/mol), 95% CI −0.57 to −0.28, p<0.001; self-monitoring of blood glucose (SMBG): −0.30% (−3.3 mmol/mol), 95% CI −0.48 to −0.013 p=0.001); there were no significant between-group differences in this respect in the analysis of covariance (ANCOVA) model (difference −0.13% (−1.4 mmol/mol), 95% CI −0.35 to 0.09; p=0.241). HbA1c was significantly decreased in the FGM group compared with the SMBG group at 24 weeks in the ANCOVA model (FGM: −0.46% (−5.0 mmol/mol), 95% CI −0.59 to −0.32, p<0.001; SMBG: −0.17% (−1.8 mmol/mol), 95% CI −0.05 to 0.11, p=0.124; difference −0.29% (−3.2 mmol/mol), 95% CI −0.54 to −0.05; p=0.022). Change in HbA1c throughout the 24 weeks analyzed using a linear mixed model showed significant improvement in the FGM group compared with the SMBG group (−0.29% (−3.2 mmol/mol), 95% CI −0.53 to −0.06; p=0.014). Data are expressed as mean (95% CI). *Significant difference between groups, p<0.05. †p<0.05 vs baseline.
Figure 2 Change in glycated hemoglobin (HbA1c). HbA1c was reduced from baseline level in both groups at 12 weeks (flash glucose monitoring (FGM): −0.43% (−4.7 mmol/mol), 95% CI −0.57 to −0.28, p<0.001; self-monitoring of blood glucose (SMBG): −0.30% (−3.3 mmol/mol), 95% CI −0.48 to −0.013 p=0.001); there were no significant between-group differences in this respect in the analysis of covariance (ANCOVA) model (difference −0.13% (−1.4 mmol/mol), 95% CI −0.35 to 0.09; p=0.241). HbA1c was significantly decreased in the FGM group compared with the SMBG group at 24 weeks in the ANCOVA model (FGM: −0.46% (−5.0 mmol/mol), 95% CI −0.59 to −0.32, p<0.001; SMBG: −0.17% (−1.8 mmol/mol), 95% CI −0.05 to 0.11, p=0.124; difference −0.29% (−3.2 mmol/mol), 95% CI −0.54 to −0.05; p=0.022). Change in HbA1c throughout the 24 weeks analyzed using a linear mixed model showed significant improvement in the FGM group compared with the SMBG group (−0.29% (−3.2 mmol/mol), 95% CI −0.53 to −0.06; p=0.014). Data are expressed as mean (95% CI). *Significant difference between groups, p<0.05. †p<0.05 vs baseline.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 173

Metadata

Authors
Wada, E., Onoue, T., Kobayashi, T., Handa, T., Hayase, A., Ito, M., Furukawa, M., Okuji, T., Okada, N., Iwama, S., Sugiyama, M., Tsunekawa, T., Takagi, H., Hagiwara, D., Ito, Y., Suga, H., Banno, R., Kuwatsuka, Y., Ando, M., Goto, M., & Arima, H.
Affiliations
  • Nagoya University (JP)
  • Research Center of Health, Physical Fitness and Sports, Nagoya University (JP)
  • Nagoya University Hospital (JP)
Corresponding author
  • Onoue, Takeshi
  • Arima, Hiroshi
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2020-06
Volume
8
Issue
1
Pages
e001115
ISSN
2052-4897 (ISSN-L)
OpenAlex
W3033947135
Cited by
157
References
31
Citations by year
2026: 22 · 2025: 35 · 2024: 38 · 2023: 28 · 2022: 18 · 2021: 15 · 2020: 1
FWCI
11.69
Type
journal article
Language
en
Open access
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
Funders
Nagoya University (the Nagoya University Hospital Funding for Clinica)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
flash glucose monitoring, continuous glucose monitoring, self-monitoring of blood glucose, type 2 diabetes, non-insulin-treated diabetes, glycemic control, HbA1c, diabetes treatment satisfaction, glycemic variability, glycemic excursions, hypoglycemia, diabetes self-management education, patient education
MeSH terms
Glycemic Control, Blood Glucose, Diabetes Mellitus, Type 2, Glucose, Humans, Hypoglycemic Agents, Japan, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. https://app.cochat.ai/papers/10.1136/bmjdrc-2019-001115
The paper
Wada, E., Onoue, T., Kobayashi, T., Handa, T., Hayase, A., Ito, M., Furukawa, M., Okuji, T., Okada, N., Iwama, S., Sugiyama, M., Tsunekawa, T., Takagi, H., Hagiwara, D., Ito, Y., Suga, H., Banno, R., Kuwatsuka, Y., Ando, M., . . . Arima, H. (2020). Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2019-001115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.